IIM
Ipswich Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Buy |
24,968
+425
| +2% | +$20.7K | 0.29% | 76 |
|
|
2025
Q1 | $835K | Sell |
24,543
-745
| -3% | -$25.4K | 0.21% | 97 |
|
|
2024
Q4 | $995K | Buy |
25,288
+750
| +3% | +$29.5K | 0.24% | 88 |
|
|
2024
Q3 | $1.15M | Buy |
24,538
+173
| +0.7% | +$8.13K | 0.27% | 79 |
|
|
2024
Q2 | $1.32M | Sell |
24,365
-480
| -2% | -$25.9K | 0.31% | 71 |
|
|
2024
Q1 | $1.69M | Buy |
24,845
+650
| +3% | +$44.3K | 0.4% | 60 |
|
|
2023
Q4 | $1.51M | Buy |
24,195
+610
| +3% | +$38.2K | 0.38% | 61 |
|
|
2023
Q3 | $1.07M | Hold |
23,585
| – | – | 0.29% | 79 |
|
|
2023
Q2 | $1.32M | Sell |
23,585
-440
| -2% | -$24.7K | 0.35% | 74 |
|
|
2023
Q1 | $1.09M | Sell |
24,025
-445
| -2% | -$20.1K | 0.3% | 81 |
|
|
2022
Q4 | $995K | Sell |
24,470
-689
| -3% | -$28K | 0.28% | 85 |
|
|
2022
Q3 | $1.64M | Sell |
25,159
-820
| -3% | -$53.6K | 0.52% | 56 |
|
|
2022
Q2 | $1.58M | Sell |
25,979
-301
| -1% | -$18.3K | 0.45% | 63 |
|
|
2022
Q1 | $1.65M | Sell |
26,280
-460
| -2% | -$28.9K | 0.41% | 71 |
|
|
2021
Q4 | $2.03M | Sell |
26,740
-720
| -3% | -$54.6K | 0.47% | 62 |
|
|
2021
Q3 | $3.07M | Buy |
27,460
+410
| +2% | +$45.9K | 0.79% | 43 |
|
|
2021
Q2 | $4.38M | Sell |
27,050
-30
| -0.1% | -$4.86K | 1.12% | 23 |
|
|
2021
Q1 | $3.3M | Sell |
27,080
-1,670
| -6% | -$204K | 0.93% | 35 |
|
|
2020
Q4 | $4.4M | Sell |
28,750
-2,680
| -9% | -$410K | 1.32% | 19 |
|
|
2020
Q3 | $2.63M | Sell |
31,430
-7,535
| -19% | -$630K | 0.84% | 40 |
|
|
2020
Q2 | $2.86M | Sell |
38,965
-1,950
| -5% | -$143K | 0.99% | 35 |
|
|
2020
Q1 | $1.74M | Sell |
40,915
-2,325
| -5% | -$98.6K | 0.68% | 47 |
|
|
2019
Q4 | $2.63M | Sell |
43,240
-485
| -1% | -$29.5K | 0.77% | 43 |
|
|
2019
Q3 | $1.79M | Sell |
43,725
-335
| -0.8% | -$13.7K | 0.57% | 54 |
|
|
2019
Q2 | $2.08M | Sell |
44,060
-95
| -0.2% | -$4.47K | 0.66% | 47 |
|
|
2019
Q1 | $1.58M | Sell |
44,155
-760
| -2% | -$27.1K | 0.52% | 59 |
|
|
2018
Q4 | $1.28M | Sell |
44,915
-1,490
| -3% | -$42.6K | 0.47% | 59 |
|
|
2018
Q3 | $2.06M | Sell |
46,405
-10,675
| -19% | -$473K | 0.7% | 49 |
|
|
2018
Q2 | $3.35M | Buy |
57,080
+5
| +0% | +$294 | 1.54% | 24 |
|
|
2018
Q1 | $2.61M | Buy |
57,075
+8,818
| +18% | +$403K | 1.1% | 28 |
|
|
2017
Q4 | $1.13M | Buy |
+48,257
| New | +$1.13M | 0.48% | 58 |
|